Cargando…

Outcome of COVID-19 Infection in Patients With Multiple Sclerosis Who Received Disease-Modifying Therapies: A Systematic Review and Meta-Analysis

BACKGROUND AND PURPOSE: A systematic review and meta-analysis was performed of the outcome of Coronavirus disease 2019 (COVID-19) infection in patients with multiple sclerosis (MS) who received disease-modifying therapies (DMTs). METHODS: Relevant studies published before November 2022 in the PubMed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ning, Yu, WuHan, Sun, Mengjiao, Zhang, Wenjing, Zhou, Dan, Sun, Jing, Wang, ManXia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329925/ https://www.ncbi.nlm.nih.gov/pubmed/36929061 http://dx.doi.org/10.3988/jcn.2022.0348

Ejemplares similares

Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response
por: Sun, Jing, et al.
Publicado: (2023)

The Top-Cited Original Articles on the Role of Microglia in Neurodegenerative Diseases: A Bibliometric and Visualized Study
por: Sun, Mengjiao, et al.
Publicado: (2022)

Long-Term Survival in Nonsurgical Esophageal Cancer Patients Who Received Consolidation Chemotherapy Compared With Patients Who Received Concurrent Chemoradiotherapy Alone: A Systematic Review and Meta-Analysis
por: Xia, Xiaojie, et al.
Publicado: (2021)

Outcome of COVID-19 infection in multiple sclerosis patients receiving disease-modifying therapies
por: Etemadifar, Masoud, et al.
Publicado: (2021)

Multiple sclerosis and stroke: a systematic review and meta-analysis
por: Hong, Ye, et al.
Publicado: (2019)

SARS-CoV-2/COVID-19 in multiple sclerosis patients receiving disease-modifying therapy
por: Adamczyk-Sowa, Monika, et al.
Publicado: (2021)

Productivity Loss and Associated Costs Among Employed Patients Receiving Disease-Modifying Treatment for Multiple Sclerosis
por: Bonafede, Machaon, et al.
Publicado: (2020)

T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapy
por: Reder, Anthony T, et al.
Publicado: (2022)

The Effect of Disease Modifying Therapies on Disability Progression in Multiple Sclerosis: A Systematic Overview of Meta-Analyses
por: Claflin, Suzi B., et al.
Publicado: (2019)

Experiences of receiving a diagnosis of multiple sclerosis: a meta-synthesis of qualitative studies
por: Topcu, Gogem, et al.
Publicado: (2022)

Disease‐modifying therapies and T1 hypointense lesions in patients with multiple sclerosis: A systematic review and meta‐analysis
por: Valizadeh, Amir, et al.
Publicado: (2022)

Vaccine Response in Patients With Multiple Sclerosis Receiving Teriflunomide
por: Tornatore, Carlo, et al.
Publicado: (2022)

Association of multiple sclerosis with vitiligo: a systematic review and meta-analysis
por: Shen, Meng-Han, et al.
Publicado: (2020)

Disease Modifying Agents for Multiple Sclerosis
por: Hilas, Olga, et al.
Publicado: (2010)

Disease-modifying agents in multiple sclerosis
por: Coyle, P. K.
Publicado: (2009)

Disease Modifying Therapy in Multiple Sclerosis
por: Williams, U. E., et al.
Publicado: (2014)

Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
por: Washington, Francesca, et al.
Publicado: (2021)

Bacterial meningitis in a patient with multiple sclerosis receiving Tysabri
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2016)

Infectious risk stratification in multiple sclerosis patients receiving immunotherapy
por: Graf, Jonas, et al.
Publicado: (2017)

Skin Reactions in Patients With Multiple Sclerosis Receiving Cladribine Treatment
por: Rolfes, Leoni, et al.
Publicado: (2021)

Yoga for Multiple Sclerosis: A Systematic Review and Meta-Analysis
por: Cramer, Holger, et al.
Publicado: (2014)

Zinc in Multiple Sclerosis: A Systematic Review and Meta-Analysis
por: Bredholt, Mikkel, et al.
Publicado: (2016)

Immune Response to Seasonal Influenza Vaccination in Multiple Sclerosis Patients Receiving Cladribine
por: Rolfes, Leoni, et al.
Publicado: (2023)

Systematic review and meta-analysis of reflexology for people with multiple sclerosis: Systematic Review and Meta-Analysis
por: Ma, Xiaohong, et al.
Publicado: (2023)

Multiple Sclerosis: Overview of Disease-Modifying Agents
por: Finkelsztejn, Alessandro
Publicado: (2014)

Oral Disease-Modifying Therapies for Multiple Sclerosis
por: Kim, Woojun, et al.
Publicado: (2015)

Editorial: Disease modifying therapies in multiple sclerosis
por: Bonavita, Simona, et al.
Publicado: (2022)

Multiple Sclerosis, Disease-Modifying Therapies, and Infections
por: Langer-Gould, Annette M., et al.
Publicado: (2023)

Adherence to Disease-Modifying Therapies for Multiple Sclerosis
por: Higuera, Lucas, et al.
Publicado: (2016)

Survival outcome among patients with out-of-hospital cardiac arrest who received cardiopulmonary resuscitation in China: a systematic review and meta-analysis
por: Zhou, Guozhong, et al.
Publicado: (2023)

The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis
por: Tsivgoulis, Georgios, et al.
Publicado: (2015)

The Effect of Disease Modifying Therapies on Brain Atrophy in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis
por: Tsivgoulis, Georgios, et al.
Publicado: (2015)

Disease-Modifying Therapy in Multiple Sclerosis: Evaluation of Patients Satisfaction in Iranian Multiple Sclerosis Population
por: Molazadeh, Negar, et al.
Publicado: (2023)

Cost-Effectiveness of Multiple Sclerosis Disease-Modifying Therapies: A Systematic Review of the Literature
por: Yamamoto, David, et al.
Publicado: (2012)

Challenges of patients with multiple sclerosis in receiving health care services in Iran
por: Jahromi, Niloofar, et al.
Publicado: (2023)

Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials
por: Zhang, Yinan, et al.
Publicado: (2020)

Chemokines and Chemokine Receptors in Multiple Sclerosis
por: Cheng, Wenjing, et al.
Publicado: (2014)

Epidemiology of multiple sclerosis in Iran: A systematic review and meta-analysis
por: Azami, Milad, et al.
Publicado: (2019)

Multiple sclerosis and ulcerative colitis: A systematic review and meta-analysis
por: Nabizadeh, Fardin, et al.
Publicado: (2023)

Efficacy and safety of siponimod for multiple sclerosis: Protocol for a systematic review and meta-analysis
por: Song, Yumeng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7gviqkbm3kjiallmn3dfd4oo2f